[基于LASSO-proj算法的可解释神经网络框架用于华法林剂量预测的应用]
Chenlu Zhong1, Ye Zhu2, Xiang Gu2
1Department of Cardiology, Gaoyou People's Hospital, Yangzhou, Jiangsu 225001, P. R. China.
概括
这项研究开发了一个可解释的机器学习模型来预测华法林剂量,提高了患者的安全性. 该模型准确地确定了用于个性化华法林治疗的VKORC1基因型,年龄和体重等关键因素.
科学领域:
- 药物基因组学 药物基因组学
- 计算生物学 计算生物学
- 临床药理学 临床药理学
背景情况:
- 华法林剂量存在挑战,因为其治疗窗口狭窄,并且具有显著的个体间变异性.
- 精确的剂量调整是困难的,增加了出血或血栓形成的风险.
研究的目的:
- 开发一种简化,可解释的多层感知子 (MLP) 模型,用于预测稳定的华法林剂量.
- 通过使用真实世界的数据,提高华法林剂量预测的准确性和透明度.
主要方法:
- 利用国际华法林制药基因组学联盟 (IWPC) 数据库来获取真实世界的数据.
- 应用了LASSO-proj算法来进行高精度的特征选择.
- 开发并解释了使用DeepExplainer进行基于SHAP的分析的多层感知子 (MLP) 模型.
主要成果:
- 该MLP模型实现了0.456的确定系数 (R^2) 和8.92 mg/周的平均绝对误差 (MAE).
- 48.52%的预测在实际稳定治疗剂量的±20%范围内.
- 确定了关键的影响因素:VKORC1基因型,体重,年龄和种族.
结论:
- 与LASSO-proj一起的可解释的MLP框架为华法林剂量提供了高的预测准确性.
- 这种方法提高了模型的透明度,为指导临床华法林治疗提供了有价值的工具.
- 个性化的华法林剂量可以通过药物遗传学见解和先进的建模来改进.
相关概念视频
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
290
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
290
Pharmacokinetic Models: Comparison and Selection Criterion
304
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
304
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
455
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
455
Drug Concentration Versus Time Correlation
1.9K
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
1.9K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
223
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
223
Pharmacokinetic Models: Overview
1.8K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.8K
